Hepatitis C testing and treatment

Auditorium IV
In programme
Thursday, 24 October, 2024 - 15:00 to 16:30
View presentations

About

This session will discuss the impact of scaling up HCV case finding and treatment for people who inject drugs, the efficacy of home-based testing methods, scaling up decentralized HCV point-of-care testing and treatment, and community-led monitoring initiatives. Attendees can expect to hear about innovative practices and collaborative approaches in the fight against HCV.

Chair

Treloar Carla
  • Scientia Professor,
  • Centre for Social Research in Health, UNSW,
  • Australia

Type

Tracks

Keywords

Presentations

Thursday, 24 October

15:00
Oral presentation

A national program to scale-up decentralized HCV point-of-care testing and treatment in Australia

15:00 to 16:30
Auditorium IV
Jason Grebely
Oral presentation

HCV Community-led monitoring: from consultation to effective policy contributions

15:00 to 16:30
Auditorium IV
Lynn Jefferys, Joana Canedo
Oral presentation

Modelling the impact of scaling up of HCV case finding and treatment for people who inject drugs in England

15:00 to 16:30
Auditorium IV
Zoe Ward
Oral presentation

Pilot HCV Birth Cohort Screening in UK Primary Care using a postal oral fluid home testing kit: the HEPCAPP StudyPP STUDY

15:00 to 16:30
Auditorium IV
Matt Hickman
View the programme